Geode Capital Management
AMIX

Geode Capital Management’s Autonomix Medical AMIX Stock Holding History

Geode Capital Management’s Portfolio AMIX Stock Details AMIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,363
Closed -$68.5K – 4579
2026
Q1 		$68.5K Buy
8,363
+7,244
+647% +$65.4K ﹤0.01% 4236
2025
Q4 		$12.9K Buy
1,119
+636
+132% +$12.3K ﹤0.01% 4420
2025
Q3 		$11K Buy
483
+5
+1% +$131 ﹤0.01% 4442
2025
Q2 		$15.8K Buy
+478
New +$17.1K ﹤0.01% 4389
2024
Q4 		– Sell
-213
Closed -$53.7K – 4519
2024
Q3 		$53.7K Buy
213
+164
+335% +$55.1K ﹤0.01% 4251
2024
Q2 		$19.9K Hold
49
– – ﹤0.01% 4453
2024
Q1 		$62.3K Buy
+49
New +$81.4K ﹤0.01% 4273

Other funds holding AMIX

Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
NA
Networth Advisors Canonsburg, Pennsylvania $172M AUM

Geode Capital Management's AMIX Position: Q2 2026 in Review

Geode Capital Management sold out of Autonomix Medical (AMIX) in Q2 2026, closing a stake of 8,363 shares — an estimated $68.5K sold.

Geode Capital Management first reported a position in AMIX in Q1 2024 and held it in 7 quarters. The position peaked at $68.5K in Q1 2026. 6 funds tracked by Wall St. Rank hold AMIX as of Q2 2026.

  • Geode Capital Management reported no remaining Autonomix Medical position as of Q2 2026 after selling out during the quarter.
  • Geode Capital Management sold 8,363 Autonomix Medical shares in Q2 2026, an estimated $68.5K.
  • Geode Capital Management first reported a position in Autonomix Medical in Q1 2024 and held it in 7 quarters.
  • Geode Capital Management's Autonomix Medical position peaked at $68.5K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Autonomix Medical as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.